Abstract
This rigorous multidisciplinary study presents strong evidence that the human SRD5A3 protein (now classified as a steroid 5-alpha reductase) is in fact the long-sought polyprenol reductase responsible for the reduction of the terminal alpha-isoprene unit of polyprenols to form dolichols. The dolichols are the essential membrane-associated carriers that feature in N-linked glycosylation in all eukaryotes. This meticulously executed and fascinating study started with a keen clinical observation that four related children might be afflicted with a congenital disorder of glycosylation (CDG). While these disorders may show a wide range of severe symptoms, a common phenotype associated with several classes of CDGs that may be a representative measure of defective N-linked glycosylation is cerebellar ataxia. This initial observation led to discovery of the involvement of the SRD5A3 gene that encoded a putative steroid 5-alpha reductase and from this followed an in depth analysis combining analytical chemistry, biochemistry, and genetics in humans, mice and yeast, which ultimately afforded excellent evidence for the true role of SRD5A3 in the earliest step of N-linked glycosylation. These studies also underscore the importance of biochemical and analytical studies in annotating gene function. An accompanying editorial by Stiles and Russell provides an excellent introduction to the research {1}. For a recent review on polyprenols in N-linked glycosylation pathways across the three kingdoms of life see {2}.